NCT06395727

Brief Summary

Opioids have always been the mainstay in management of patients during cardiac surgeries. Mega doses are often used to relieve stress of surgeries in highly labile patients with narrow hemodynamic threshold to keep the balance between oxygen demand and supply. Unfortunately, this is associated with hemodynamic instability and affect the fast-track pathway for extubation. Most of these doses are given in induction, so by blocking airway by non-invasive technique, this will help in the reduction in opioid doses and preventing risky hemodynamic instability during induction of anesthesia in these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Apr 2024

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 2, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2024

Completed
Last Updated

September 11, 2025

Status Verified

March 1, 2024

Enrollment Period

7 months

First QC Date

April 29, 2024

Last Update Submit

September 5, 2025

Conditions

Keywords

cardiac, airway block, lidocaine spray

Outcome Measures

Primary Outcomes (1)

  • Hemodynamic instability

    Hemodynamic instability before induction, before intubation and 30 seconds, 1 minute and 2 minutes after intubation then every 5 minutes till skin incision.

    from induction to skin incision

Secondary Outcomes (2)

  • Total doses of vasoactive drugs used

    from induction to skin incision

  • Total doses of opioids used

    through out the operation

Study Arms (2)

• Traditional balanced anaesthesia (control group)

EXPERIMENTAL

Analgesia will be offered by fentanyl 3-5 mic/kg in induction

Drug: Fentanyl

• Airway topical anaesthesia

EXPERIMENTAL

Patient will be given lidocaine nebulizer (5 ml of lidocaine 2% with oxygen flow 8 l/m) after radial arterial catheter insertion that will be complemented by topical application of lidocaine spray 10 % not to exceed 200mg per dose on mouth with encouraging to move it in mouth then gargling with it before swallowing targeting reaching difficult swallowing.

Drug: Lidocain

Interventions

traditional fentanyl dose

• Traditional balanced anaesthesia (control group)

lidocaine nebuliser and lidocaine spray targeting difficult swallowing

• Airway topical anaesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing elective cardiac surgery.
  • Age: above 18

You may not qualify if:

  • Pregnant or breast-feeding women
  • Emergency surgery
  • Anticipated difficult airway
  • Allergy to any of the drugs used in the study
  • Cannot cooperate to complete topical anaesthesia (with mental disorders or unable to communicate)
  • Use of a left ventricular assist device, IAB or ECMO prior to surgery
  • Presence of aortic dissection
  • EF\<40 %
  • Severe mitral valve stenosis or severe aortic valve stenosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Abdallah

Cairo, 02, Egypt

Location

Abdallah Mahmoud Zaki Soudi

Cairo, Egypt

Location

MeSH Terms

Interventions

Fentanyl

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Anaesthesia will be provided according to the hospital protocol in respect to preoperative investigations, fasting hours and intra-operative monitoring and drugs. All patients will be monitored by ECG, pulse oximeter and non-invasive blood pressure monitoring before receiving 2 mg midazolam for sedation before radial artery catheter insertion. After arterial catheter insertion, patients will be allocated to two groups, the first one (TBA group) will receive fentanyl traditional dose 3-5 mic/kg during induction. The second group will sit and receive lidocaine 2% nebulizer and then lidocaine 10 % oral application till achieving difficult swallowing. Then patient will lie, and induction will be done by fentanyl at a dose max 1 mic/kg. Then, both groups will receive general anaesthesia induction. Hemodynamic parameters will be recorded before induction, before intubation, 30 seconds, 1 minute and 2 minutes after intubation then every 5 minutes till skin incision.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2024

First Posted

May 2, 2024

Study Start

April 25, 2024

Primary Completion

November 13, 2024

Study Completion

December 28, 2024

Last Updated

September 11, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
6 months

Locations